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ABSTRACT  
          Chocolate is highly sophisticated and infinitely a versatile 
food that can be combined to create completely different taste and 
texture sensations.  The objective of the present study is to 
develop a palatable chocolate formulation of Domperidone and 
Cetirizine for pediatric administration and to increase patient’s 
desire to consume the medication. In present investigation 
chocolate base is prepared by use of cocoa powder, coco butter, 
lecithin, and pharmaceutical grade sugar. Thereafter drug is 
incorporated to prepared chocolate base. The medicated chocolate 
prepared is evaluated for appearance, moisture content 
determination using digital Karl Fischer titrator, blooming test, drug 
content determination & drug excipient interaction by differential 
scanning calorimetry. 
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INTRODUCTION  
Chocolate is highly sophisticated a 
versatile food that is combined to create 
completely different taste and texture 
sensations. Chocolate is also an anhydrous 
medium and is therefore resistant to microbial 
growth and to hydrolysis of water-sensitive 
active agents. Chocolate is well-suited as a 
vehicle for delivering active agents in many 
aspects. For example, the organoleptic 
characteristics of chocolate are excellent for 
masking unpleasant flavors associated with 
some active agents and giving a smooth and 
creamy texture to compositions of active agents 
that are otherwise undesirably gritty(Lang, 
2007). Chocolate abundantly contains 
compounds such as saturated fat, polyphenols, 
sterols, di and triterpenes, aliphatic alcohols, 
and methylxanthines (Knight, 2000). Cocoa is 
the principle ingredient of chocolate and it is 
rich in polyphenols, particularly in flavan-3-ols 
such as epicatechins, catechins, and 
procyanidins (Lamuela-Raventos et al., 2001; 
Hammerstone et al., 2000; Scalbert et al., 2000; 
Adamson et al., 1999; Lazarus et al., 1999). 
Research studies suggest that a high intake of 
dietary flavonoids, a subgroup of polyphenols, 
may reduce the risk of coronary heart disease 
(Geleijnse et al., 1999; Hertog et al., 1995). The 
antioxidant properties of flavonoids may 
partially account for the protective effect 
(Fuhrman et al., 2001). Taste is defined as “the 
sensation of flavor perceived in the mouth on 
contact with a substance”. A food or 
medication that is palatable is one that is 
“pleasant to taste” (Oxford Dictionary, 2007). 
The primary cells for taste are modified 
epithelial cells that are grouped in taste buds 
and are found in the taste papillae of the tongue 
(Llorens et al., 2004). There are four basic taste 
modalities, sweet, salty, sour and bitter. 
Children’s tastes sensation is differ from adults 
(Mennella et al., 2005). Infants and children 
have a preference for sweet-tasting substances 
(Lawless et al., 1985) that decreases to resemble 
that of adults during late adolescence (Liem et 
al., 2002). On the other hand, aversion to 
bitterness appears from a very early age and, 
therefore, bitter flavors are likely to decrease 
palatability. Indeed, addition of aversive 
bittering agents has been proposed as a method 
of preventing toxic ingestions in young children 
(Rodgers et al., 1994). 
 
METHODOLOGY 
Materials and methods 
Cetirizine, Domperidone, Lecithin, 
Pharmaceutical grade sugar was obtained as a 
gift sample from Alpa Laboratories (Indore, 
M.P, India.), Schon Pharmaceuticals (Indore, 
M.P, India.),  Sonic Biochem (Indore, M.P, 
India.),  Yash   Pharma  Sugars  (Navi  Mumbai,  
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M.H, India), respectively Cocoa Butter was  
purchased from Merck Chemicals (India), and 
Cocoa powder purchased  from Nestle India. 
All the other chemicals and reagents used are of 
analytical grade. 
 
Formulation of chocolate Base 
Chocolates were formulated with total 
fat of 25–35% (w/w) from cocoa liquor and 
cocoa butter with more than 34% total cocoa, 
composition as specified for dark chocolate  
(European Commission Directive, 2000; Codex 
Revised Standard, 2003) (Table I) (Afoakwa, 
2010). 
 
Method of preparation 
Oven was set to 50ºC. In a beaker, sugar 
and water was taken and kept  in  the oven for 
4-5 min and  syrup was prepared. Then cocoa 
butter was taken and kept in  the beaker in the 
oven for 1 min. Then sugar syrup was removed 
from the oven, and cocoa powder was added 
and mixed well. Careful attention is paid to the 
chocolate manufacturing process to ensure that 
the temperature of the mixture is not too high. 
Then above mixture of chocolate base was 
cooled up to semisolid consistency and then 
flavor was added. 
 
Formulation of medicated chocolate 
Chocolate squares containing drug in 
appropriate quantity is known as medicated 
chocolate. 
 
Method of preparation 
Oven was set at 50°C. Then chocolate 
base was melted till it becomes free flowing 
liquid. After above step; required quantity of 
drug was added. Then whole mass was stirred 
well with the help of magnetic stirrer to ensure 
uniform mixing. Then we poured the above 
mixture in a polycarbonate set mould and 
refrigerated for 15 min till it become solid. 
 
Evaluation of chocolate base 
Viscosity determination of chocolate 
base 
Brookfield Rotational digital viscometer 
(DV I+) was used to measure the viscosity (in 
cps) of the prepared chocolate base. The 
spindle (LV1) was rotated at 20rpm; Samples of 
chocolate base were heated at 50°C before the 
measurements were taken. 
Taste, texture and mouth feel 
characteris-tics assessment 
Taste, texture & mouth feel 
characteristics of chocolate were evaluated by 
taking panel of 10 human volunteers on a 
rating scale of 1-5 (Table II). 
 
Evaluation of Medicated chocolates 
General Appearance 
The general appearance of a chocolate 
formulation, its visual identity and overall 
“elegance,” is essential (i) For Consumer 
acceptance (ii) For control of lot to lot 
uniformity and (iii) For monitoring trouble free 
manufacturing. The control of the general 
appearance of a chocolate involve the 
measurement of number of attributes such as 
chocolate’s color, presence or absence of an 
odor, taste, surface texture and physical flaws. 
 
Dimensions 
The dimension of chocolate was 
measured by vernier’s calipers. 
 
Moisture content determination 
Moisture content of chocolate 
formulation is determined by using Digital Karl 
Fischer Titrator  model Veego/Matic.  
These instruments are designed to 
calculate percentage (%) water content by using 
formula: 
Water = [Volume (mL) TS of water 
determination consumed x f 
(mg/m)/weight of sample (mg)]    
x 100 (%) 
Where, 
f = the number of mg of water (H2O) 
corresponding to 1mL of water 
Determination TS,  




When a thin layer of fat crystals forms 
on the surface of the chocolate formulation. 
This will cause the chocolate to lose its gloss 
and a soft white layer will appear, giving the 
finished article an unappetizing look. Fat bloom 
is caused by the recrystallization of the fats 
and/or a migration of a filling fat to the 
chocolate layer. Storage at a constant 
temperature will delay the appearance of fat 
bloom.  
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Sugar bloom 
This is a rough and irregular layer on top 
of the chocolate formulation. Sugar bloom is 
caused by condensation (when the chocolate is 
taken out of the refrigerator). This moisture will 
dissolve the sugar in the chocolate. When the 
water evaporates afterwards, the sugar 
recrystallizes into rough, irregular crystals on 
the surface. This gives the chocolate an 
unpleasant look. 
Each sample was subjected to treatment 
cycles comprised (1) 30°C for 11 hours, (2) 
temperature shifting for 1 hour, (3) 18°C for 11 
hours, and (4) temperature shifting for 1 hour. 
A test chocolate formulation observed, after 
the step at 18°C for 11 hours, whether or not 
blooming has taken place. 
 
Drug-excipients interaction study 
Differential scanning calorimetery 
Drug–Excipient interaction study was 
performed by Differential scanning 
calorimetery    (MDSC by TA instruments US.) 
was performed in Thermodynamic laboratory 




This study was performed to determine 
any interaction or physical changes that may 
occur when kept with various excipients at 
different environmental conditions. Drug was 
mixed with various excipients in the ratio of 1:5 
and was kept in closed vials. These vials were 
placed at 25ºC for 1 month. The vials kept at 2-
8ºC were considered to be control samples. 
After one-month interval, sample vials were 
withdrawn from each test group and physical 
appearance and drug degradation was observed. 
 
Drug content determination 
Drug content of a medicated chocolate 
was determined by using UV Spectrometer. 
 
Method of sample preparation 
For Domperidone medicated chocolate 
cube: Medicated chocolate was taken in 25mL 
beaker. Then mixed in 10mL of methanol, it 
dissolves drug, then this mixture is sonicated 
well in bath sonicator. Sonication ensures 
proper mixing of medicated chocolate cube 
with methanol. Then this sonicated sample is 
poured in a centrifuge tubes. It is then 
Table I. Preparation of chocolate base 
 
Sr.no. Ingredients Uses Quantity 
1 Pharmaceutical grade sugar Sweetening agent 40.8g 
2 Cocoa butter Solidifying agent 5g 
3 Cocoa powder Principal ingredient 53.7g 
4 Lecithin Emulsifier 0.5g 
 
Table II. Taste, texture and  mouth feel characteristics assessment 
 
S.no Characters Criteria Scale 
1. Appreanace Glossy, even shine; no streaks, dots, 
cracks or “fog” 




Aroma or Smell Chocolaty with only a light scent of any 
flavourings; fresh with no burnt, 
smoky, chemical smells 
1-5 with 5 being the 
best. 
3. Snap Break clean without crumbling or 
layering; ideally a crisp pop when 
broken (loudest for dark chocolate) 
1-5 with 5 being the 
best. 
4. Taste Chocolaty, flavours not overpower the 
chocolate taste. Good aftertaste 
1-5 with 5 being the 
best. 
5. Texture Creamy and smooth, not waxy; 
promptly and evenly melts in mouth 
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centrifuged for 15min at 2500rpm. 
Centrifugation leaves two layer upper one is 
clear liquid containing drug dissolved in it as 
drug is slightly soluble in methanol and leaving 
other solid layer of chocolate base. This 
supernatant is then filtered to remove any 
traces of chocolate remaining in it. Then this 
liquid sample is analyzed using by UV 
spectrophotometer against methanol as a blank. 
For Cetirizine medicated chocolate 
cubes: Medicated chocolate was taken in 25mL 
beaker. Then mixed in 10mL of distilled water, 
water dissolves drug in it as Cetirizine is freely 
soluble in water. Then same above process is 
repeated  as for sample preparation of  
domperidone medicated chocolate cube. Then 
this liquid sample is analyzed using by UV 




In vitro drug Release 
In vitro drug release study of Chocolate 
formulation was performed in USP dissolution 
apparatus Type 1 (Basket), using 0.1N HCl as a 
dissolution media. The bowls of the dissolution 
tester was filled with 900mL of 0.1N HCl was 
placed and allowed to attain a temperature of 
37±0.5ºC and 50rpm. A chocolate formulation 
was placed in the basket. At predetermined 
time interval i.e. 1, 2, 3, up to 10 minutes, 10mL 
sample was withdrawn and volume was 
replaced with equal quantity of fresh medium. 
The collected samples were filtered and 
analyzed by UV Spectroscopy. The 
concentration of Cetirizine & Domperidone 
was calculated using slope of calibration curve 
and cumulative percentage release was 
calculated. 
Table III. General appearance  
 
S. No. Characteristics Result 
1 Colour Dark brown 
2 Odour Pleasant 
3 Taste Semisweet 
4 Surface texture Smooth 
   
Table IV. Moisture content determination (Karl Fischer Titration) 
 
Moisture Content(n=3) Percentage(%) 
S. No. Incubation Period 
CDF CCF 
1 Fresh 0.475+ 0.2 0.153+0.13 
2 24 hr 0.492+0.17 0.166+0.02 
3 48 hr 0.512+0.11 0.183+0.16 
 
+ denotes standard Deviation 
 
Table V. Percentage cumulative drug release profile of cetirizine 
 
Sr. No. Time (Min) Release(%) 
1 0 00.00±0.0 
2 10 20.36±0.22 
3 20 32.72±0.28 
4 30 49.51±0.72 
5 40 65.44±0.82 
6 50 78.98±0.77 
7 60 84.86±0.32 
8 70 91.09±0.18 
9 80 97.72±0.76 
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Stability test 
It is the responsibility of the manu-
facturers to see that the medicine reaches the 
consumer in an active form. So the stability of 
pharmaceuticals is an important criterion. 
Stability of medicinal products may be defined 
as the capability of a particular formulation in a 
specific container to remain within its         
physical,  chemical,  microbial,  therapeutic  and  
 
toxicological specification, i.e. stability of drug 
is its ability to resists detoriation. 90% of 
labeled potency is generally recognized as the 
minimum acceptable potency level. Detoriation 
of drug may take several forms arising from 
changes in physical, chemical and 
microbiological properties. The changes may 
affect the therapeutic value of preparation or 
increase its toxicity. 
Table VI. Percentage Cumulative drug release profile of  Domperidone  
 
Sr. No. Time (Min)  Release(%) 
1 0 00.00+0.32 
2 10 18.86+0.27 
3 20 28.52+0.56 
4 30 44.31+0.82 
5 40 62.54+0.63 
6 50 76.88+0.38 
7 60 88.36+0.77 
8 70 94.19+0.71 
9 80 98.76+0.45 
 
 
Table VII. Stability Study 
 
S. No. Storage Condition for  one months General Appearance Drug Content 
1. 2-8 ºC (Controlled ) No change 98.23+0.16 
2. 25ºC/75% RH No change 96.12+0.11 
   
+ denotes Standard Deviation (SD) 
 
 
Figure 1. DSC thermogram of chocolate base 
 
Figure 2. DSC thermogram of cetirizine 
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Accelerated stability testing 
Since the period of stability testing can 
be as long as two years, it is time consuming 
and expensive. Therefore it is essential to 
devise a method that will help rapid prediction 
of long-term stability of drug. The accelerated 
stability testing is defined as the validated 
method by which the product stability may be 
predicted by storage of the product under 
conditions that accelerate the change in defined 
and predictable manner. The stability studies of 
formulated formulations were carried out at 
25/75(ºC/RH) and 2-8ºC for one month. The 
effects of temperature, humidity and time on 
the general appearance of chocolate and drug 
content were evaluated for assessing the 
stability of the prepared formulations. 
 
Moisture content determination for 
stability studies 
Moisture content of chocolate 
formulation is determined by using Digital Karl 
Fischer Titrator model Veego/Matic after the 3 
months of initial sample were tested to check 
levels of moisture for stability testing  
 
 
Figure 3. DCS thermogram of domperidone       
        
 
 






Figure 5. DSC thermogram of chocolate 
base and domperidone 
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RESULTS AND DISCUSSIONS 
Evaluation 
Evaluation of chocolate base 
Viscosity determination of chocolate 
base 
Viscosity of chocolate base was 
determined by Brookfield Rotational Digital 
Viscometer (DV I+) and was found to be 
62,326cps±0.62. 
 
Taste, texture & mouth feel characteris-
tics assessment of chocolate base 
Taste, Texture & Mouth Feel 
Characteristics of chocolate base was 
determined by using 10 Human Volunteers & it 
was found to be satisfactory. It was scaled 1-5 
under following characters. 
 
Evaluation of medicated chocolate 
Following evaluations were performed 
on chocolate formulation. 
 
General appearance 
Prepared formulations are semi-
curvature in shape with length, width and 
height of 28.5, 18 and 14mm respectively 
(Table III). 
 
Moisture content determination 
Moisture content determination was 
done by Digital Karl Fischer Titrator and it was 
found as shown in Table IV. 
 
Blooming test 
There is no blooming was observed in 
any formulation 
Figure 6. Percent cumulative drug release profile of Cetirizine from 
chocolate formulation 
 
Figure 7. Percent  cumulative drug release profile of Domperidone from 
chocolate formulation 
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Drug-excipients interaction study 
The DCS thermogram of chocolate, 
cetirizine, domperidone, chocolate-cetirizine, 
and chocolate-domperidone were showed in 
Figure 1-5. 
 
Drug excipients stability study 
The drug mixed with various excipients 
at different environmental conditions for one 
month was found to be stable in closed 
conditions. Thus, it was concluded that above 
excipients are compatible with cetirizine and 
domperidone as no interaction was found. 
 
Drug content 
For Cetirizine medicated chocolate 
square drug content was found to be 
9.89+0.33mg and for Domperidone medicated 
chocolate square drug content was found to be 
9.86+0.68mg (Table V and VI). 
 
In vitro drug release 
Chocolate formulation was subjected to 
in vitro drug release using 0.1N HCl. 
Dissolution data shows that formulation 
releases complete drug within 80min (approx). 
 
Moisture content determination 
Moisture content of chocolate 
formulation was determined by using Karl 
Fischer titration Method. For stability studies 
moisture was determined after three months of 
initial sample and was found to be satisfactory 
(Table VII). 
Cetirizine and Domperidone are 
available in various oral dosage forms. Oral 
ingestion is the most common way in which 
medications are administered. However, many 
people consider oral forms of medications to 
be unpalatable. Thus, keeping this thing under 
consideration, it was planned to develop a 
palatable chocolate formulation of 
Domperidone and Cetirizine for pediatric 
administration and to increase a patient’s desire 
to consume the medication. The aim of present 
study was to effectively mask bitter taste of 
Cetirizine and Domperidone and to make them 
more palatable among pediatric patients. The 
chocolate formulation was prepared containing 
Domperidone and Cetirizine. The prepared 
chocolate formulation was evaluated for general 
appearance, moisture content, bloom test, and 
DSC. The results indicate that the formulation 
was stable and there was no degradation in 
drug during chocolate formulation preparation. 




Chocolate formulation has not found 
commercial acceptance for delivery of 
pharmaceutical or nutraceutical agent, owing in 
part to the difficulty of formulating chocolate 
compositions which comprise particulate active 
agents. But it has been found that chocolate 
dosage forms may be formulated by carefully 
controlling the particle size of the particulate 
active agent. The organoleptic characteristics of 
chocolate are excellent for masking unpleasant 
flavors associated with some active agents and 
imparting a smooth and creamy texture to 
compositions of active agents. Thus chocolate 
formulations provide a palatable means for 
delivering medicaments through oral delivery. 
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